Volume 11, Issue 4 (2023)
Health Educ Health Promot 2023, 11(4): 681-686 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Rusli Bintang M, Bachtiar A, Candi C. Designing a Tuberculosis E-Screening Tool for Diabetes Mellitus Patients. Health Educ Health Promot 2023; 11 (4) :681-686
URL: http://hehp.modares.ac.ir/article-5-72600-en.html
URL: http://hehp.modares.ac.ir/article-5-72600-en.html
1- Faculty of Public Health, University of Indonesia, Depok, Indonesia
Abstract: (391 Views)
Aims: Indonesia is ranked as the 2nd highest country with tuberculosis burden worldwide. Diabetes mellitus (DM) is among the top five causes of death in Indonesia. Patients with DM are facing an elevated risk of tuberculosis. Private primary care centers contribute only up to 0.6% of the reported tuberculosis cases. To enhance tuberculosis notification rates, we developed an electronic tuberculosis screening tool for DM patients within private primary care centers.
Instrument & Methods: The initial phase of this descriptive study employed a quantitative approach, utilizing secondary data analysis from the RISKESDAS database to discern tuberculosis prevalence in DM patients. The second phase adopted a qualitative approach, incorporating interviews with private primary care centers regarding the current tuberculosis reporting process. The third stage involved system development of the e-screening tool. The fourth stage was a pilot project to evaluate the effectiveness of the e-screening tool prototype in increasing tuberculosis notification rates among DM patients. Two private primary care centers served as a setting to conduct the pilot project.
Findings: There were 33 patients with a high risk for tuberculosis. These patients were referred to the nearest Puskesmas for further tests. Ultimately, two patients were diagnosed with tuberculosis in four weeks of e-screening trial tests.
Conclusion: This research led to the development of a TB e-screening tool for DM patients, intended to improve tuberculosis notification rates in private primary care centers.
Instrument & Methods: The initial phase of this descriptive study employed a quantitative approach, utilizing secondary data analysis from the RISKESDAS database to discern tuberculosis prevalence in DM patients. The second phase adopted a qualitative approach, incorporating interviews with private primary care centers regarding the current tuberculosis reporting process. The third stage involved system development of the e-screening tool. The fourth stage was a pilot project to evaluate the effectiveness of the e-screening tool prototype in increasing tuberculosis notification rates among DM patients. Two private primary care centers served as a setting to conduct the pilot project.
Findings: There were 33 patients with a high risk for tuberculosis. These patients were referred to the nearest Puskesmas for further tests. Ultimately, two patients were diagnosed with tuberculosis in four weeks of e-screening trial tests.
Conclusion: This research led to the development of a TB e-screening tool for DM patients, intended to improve tuberculosis notification rates in private primary care centers.
Keywords: Tuberculosis [Mesh], Disease Notification [MeSH], Mass Screening [MeSH], Diabetes Mellitus [MeSH]
Article Type: Original Research |
Subject:
Health Promotion Approaches
Received: 2023/10/24 | Accepted: 2023/12/6 | Published: 2023/12/22
Received: 2023/10/24 | Accepted: 2023/12/6 | Published: 2023/12/22
References
1. World Health Organization. Tuberculosis (TB) [Internet]. Geneva: WHO. 2023- [cited 2023 Oct 1]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/tuberculosis [Link]
2. Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulm Med. 2013;2013:828939. [Link] [DOI:10.1155/2013/828939]
3. Odone A, Houben RM, White RG, Lönnroth K. The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets. Lancet Diabetes Endocrinol. 2014;2(9):754-64. [Link] [DOI:10.1016/S2213-8587(14)70164-0]
4. Nazriati E, Zulharman Z, Chandra F, Putri UA. Public-Private Mix Implementation and Achievements of Tuberculosis Control Program at Puskesmas in Pekanbaru. Mutiara Medika Journal of Medicine and Health. 21(2):86-94. [Indonesian] [Link] [DOI:10.18196/mmjkk.v21i2.11731]
5. Anggraini RD, Rahayu EP, Orianti WO. Evaluation of tuberculosis recording and reporting case system at syarif hidayatullah hospital in 2020. Berita Kedokteran Masyarakat.;34(11). [Indonesian] [Link]
6. Ratnasari Y, Sjaaf AC. Evaluation of tuberculosis recording and reporting case system at syarif hidayatullah hospital in 2020. J Admin Rumah Sakit Indonesia. 2023;9(1):21-4. [Link] [DOI:10.7454/arsi.v9i1.4742]
7. Tenaye L, Mengiste B, Baraki N, Mulu E. Diabetes mellitus among adult tuberculosis patients attending tuberculosis clinics in Eastern Ethiopia. Biomed Res Int. 2019;2019. [Link] [DOI:10.1155/2019/7640836]
8. Wu Q, Liu Y, Ma YB, Liu K, Chen SH. Incidence and prevalence of pulmonary tuberculosis among patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Ann Med. 2022;54(1):1657-66. [Link] [DOI:10.1080/07853890.2022.2085318]
9. Al-Rifai RH, Pearson F, Critchley JA, Abu-Raddad LJ. Association between diabetes mellitus and active tuberculosis: A systematic review and meta-analysis. PloS One. 2017;12(11):e0187967. [Link] [DOI:10.1371/journal.pone.0187967]
10. Hidayah H, Amal S, Rosmalinda AN. Incidence of Pulmonary TB in Type 2 DM Patients at Karya Husada Cikampek Hospital. Pharma Xplore: J Sains dan Ilmu Farmasi. 2021;6(1):23-31. [Indonesian] [Link] [DOI:10.36805/farmasi.v6i1.1446]
11. Aldabbagh MA, Abughasham A, Alansari G, Bougis S, Melibari E, Alhatmi N, et al. The prevalence of mycobacterium tuberculosis infection among cancer patients receiving chemotherapy in a tertiary care center. Cureus. 2022;14(11):e32068. [Link] [DOI:10.7759/cureus.32068]
12. Nugroho NP, Wati FF. Coexistence of Lung Cancer and Tuberculosis. Syifa'Med J Kedokt dan Kesehat. 2020;11(1):49. [Indonesian] [Link] [DOI:10.32502/sm.v11i1.2583]
13. Bae S, Kim YJ, Kim MJ, Kim JH, Yun SC, Jung J, et al. Risk of tuberculosis in patients with cancer treated with immune checkpoint inhibitors: A nationwide observational study. J Immunother Cancer. 2021;9(9);e002960. [Link] [DOI:10.1136/jitc-2021-002960]
14. Widada S. Achievements of the TB and Public Private Mix Control Program in Indonesia. Jakarta: Directorate General of P2P Ministry of Health of the Republic of Indonesia; 2022. [Indonesian] [Link]
15. Wadudah F, Prasetyowati I, Bumi C. Implementation of Mandatory TB Notification (WiFi) at the Jember District Health Service. Pustaka Kesehatan. 2020;8(2):131-8. [Indonesian] [Link] [DOI:10.19184/pk.v8i2.20360]
16. Kurniawati A, Padmawati RS, Mahendradhata Y. Acceptability of mandatory tuberculosis notification among private practitioners in Yogyakarta, Indonesia. BMC Res Notes. 2019;12:543. [Link] [DOI:10.1186/s13104-019-4581-9]
17. Ratnasari Y, Sjaaf AC, Djunawan A. Evaluation of the Tuberculosis Case Recording and Reporting System at Syarif Hidayatullah Hospital. J Manajemen Kesehatan Yayasan RS Dr. Soetomo. 2021;7(1):115-24. [Indonesian] [Link] [DOI:10.29241/jmk.v7i1.608]
18. Tandama'dika R, Qashlim AA, Khairat U. Integration of Hospital Information Systems for Health Facilities and Referral Services. Proceeding KONIK (Konferensi Nasional Ilmu Komputer). 2021;5:406-12. [Indonesian] [Link]
19. Suhadi S, Jumakil J, Irma I. Aplikasi Mobile JKN untuk Memudahkan Akses Pelayanan BPJS. J Health Res Forikes Voice. 2022;13:262-7. [Link]
20. Wardiah R, Izhar MD, Lanita U. Study of the effectiveness of the JKN mobile application on Jambi City National Health Insurance (JKN) participants. J Endurance. 2022;7(3):607-14. [Indonesian] [Link] [DOI:10.22216/jen.v7i3.1664]
21. Zhou D, Pender M, Jiang W, Mao W, Tang S. Under-reporting of TB cases and associated factors: A case study in China. BMC Public Health. 2019;19:1664. [Link] [DOI:10.1186/s12889-019-8009-1]
22. Iskandar D, Suwantika AA, Pradipta IS, Postma MJ, van Boven JF. Clinical and economic burden of drug-susceptible tuberculosis in Indonesia: National trends 2017-19. Lancet Glob Health. 2023;11(1):e117-25. [Link] [DOI:10.1016/S2214-109X(22)00455-7]
23. Nuryani S, Nursilmi DL, Sonia D. Analysis of the system for recording and reporting tuberculosis cases at the X general hospital in Bandung City. Cerdika: J Ilmiah Indonesia. 2021;1(11):1601-7. [Indonesian] [Link] [DOI:10.36418/cerdika.v1i11.232]
24. Paskaria C, Sunjaya DK, Parwati I, Bestari MB. Digital health to strengthen district-based public-private mix tuberculosis control in Purwakarta district, Indonesia: A qualitative research. Int J Environ Res Public Health. 2022;19(19):12097. [Link] [DOI:10.3390/ijerph191912097]
25. Arini M, Sugiyo D, Permana I. Challenges, opportunities, and potential roles of the private primary care providers in tuberculosis and diabetes mellitus collaborative care and control: A qualitative study. BMC Health Serv Res. 2022;22(1):215. [Link] [DOI:10.1186/s12913-022-07612-3]
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |